ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/10/2025
Voltar para busca
Dado oficial do USPTO
GENLINK3D
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
GENLINK3D
ST13
US500000097691779Classe
9, 35, 42
Pedido
97691779
Registro
7895843
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
16/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 42
Data de depósito
25/11/2022
Data de registro
19/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/08/2025
Última transação
16/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
78
Localização do titular
CAMBRIDGE, GB
Examinador
ANDERSON,DANIELLE LYNN
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
E. G. (pessoa física)
ENHANC3D GENOMICS LTD
Representantes
Emily M. Chilson ANDRUS INTELLECTUAL PROPERTY LAW, LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Downloadable software for visualisationanalysismanipulation of biological molecules in the field of genomics; Downloadable software for visualisationanalysismanipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Scientific research apparatus and instruments being laboratory devices for detecting genetic sequences by profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Electronic database in the field of genomics recorded on computer media; Downloadable educational publicationsprintable workbooksbookletsscientific journalsarticles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of drug discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of medical diagnosis; Downloadable electronic publications in the nature of scientific journals and articles in the field of biomarker discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of bioinformatics
Classe 35
Business data analysis in the field of drug discovery; Business data analysis in the field of medical diagnosis; Business data analysis in the field of biomarker discovery; Business data analysis in the field of genomics; Business data analysis in the field of bioinformatics; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and statistical reporting services for business purposes; Business information services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Business consulting services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Market intelligence services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business advisory servicesconsultancy and information
Classe 42
Software as a service (SAAS) services featuring software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Software as a service (SAAS) services featuring software for analyzing biological data for research and development of drugs in the field of genomics; Software as a service (SAAS) services featuring software for diagnosis of genetic diseases by analyzing biological data; Software as a service (SAAS) services featuring software for development of biomarkers for medical treatment; Software as a service (SAAS) services featuring software for collectionanalysis and interpretation of biological data; Software as a service (SaaS) services featuring software for visualisationanalysismanipulation of biological molecules; Software as a service (SaaS) services featuring software for modelling and prediction of biological interactions; Software as a service (SaaS) services featuring software for genome sequencing; Software as a service (SAAS) services featuring software for data analysisdata processing and database management in the field of genomics; Software as a service (SAAS) services featuring software for data analysis for research and development of artificial intelligence and machine learning in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for data analysisdata processing and database management in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for analyzing biological data for research and development of drugs in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for diagnosis of genetic diseases by collecting and analyzing biological data; Platform as a service (PAAS) featuring computer software platforms for development of biomarkers for medical treatment; Platform as a service (PAAS) featuring computer software platforms for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Platform as a service (PAAS) featuring computer software platforms for collectionanalysis and interpretation of biological data; Platform as a service (PaaS) featuring computer software platforms for visualisationanalysismanipulation of biological molecules; Platform as a service (PaaS) featuring computer software platforms for modelling and prediction of biological interactions; Platform as a service (PaaS) featuring computer software platforms for genome sequencing; Platform as a service (PaaS) featuring computer software platforms for performing data analysisdata processingdatabase management in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for machine learning in the field of genomics; Design and development of software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Design and development of computer software in the field of data analysis for drug discovery; Design and development of computer software in the field of data analysis for medical diagnosis; Design and development of computer software in the field of collection and analysis of biological data for biomarker discovery; Design and development of computer software in the field of genomic analysis; Design and development of computer software in the field of bioinformatic analysis; Design and development of computer software for visualisationanalysismanipulation of biological molecules; Design and development of computer software for modelling and prediction of biological interactions; Design and development of computer software for genome sequencing; Design and development of computer software for performing data analysis in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Design and development of computer software using artificial intelligence for machine learning in the field of genomics; Scientific research services for others in the field of genomics; Scientific research services for others in the field of drug discovery; Scientific research services for others in the field of medical diagnosis; Scientific research services for others in the field of biomarker discovery; Scientific research services for others in the field of bioinformatics; Scientific research consulting services in the field of drug discovery; Scientific research consulting services in the field of medical diagnosis; Scientific research consulting services in the field of biomarker discovery; Scientific research consulting services in the field of genomics; Scientific research consulting services in the field of bioinformatics; Scientific and technological servicesscientific research and analysis featuring profiling three-dimensional genome folding at high resolution for all genes and their enhancersin the field of genomics; Scientific and technological servicesscientific testing in the field of drug discovery; Scientific and technological servicesscientific testing in the field of medical diagnosis; Scientific and technological servicesscientific testing in the field of biomarker discovery; Scientific and technological servicesscientific testing in the field of genomics; Scientific and technological servicesscientific testing in the field of bioinformatics; Computer programming services for scientific data processing; Providing temporary use of on-line non-downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Compiling data for research purposes in the field of medical science; Advisory services relating to computer software design for genomic analysis; Consultancy in the field of software design for genomic analysis; Providing information in the field of scientific research in the field of genomics; Compiling data for scientific research purposes in the field of medical science
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
19/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2025
PUBO
PUBLISHED FOR OPPOSITION
03/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/01/2025
GNRT
NON-FINAL ACTION E-MAILED
11/01/2025
CNRT
NON-FINAL ACTION WRITTEN
11/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/09/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2024
GNRT
NON-FINAL ACTION E-MAILED
03/06/2024
CNRT
NON-FINAL ACTION WRITTEN
03/06/2024
DOCK
ASSIGNED TO EXAMINER
18/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/03/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
13/12/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
13/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/09/2023
GNRT
NON-FINAL ACTION E-MAILED
18/09/2023
CNRT
NON-FINAL ACTION WRITTEN
18/09/2023
DOCK
ASSIGNED TO EXAMINER
06/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/12/2022
NWAP
NEW APPLICATION ENTERED
29/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENLINK3D ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.